<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00965146</url>
  </required_header>
  <id_info>
    <org_study_id>48</org_study_id>
    <nct_id>NCT00965146</nct_id>
  </id_info>
  <brief_title>Scorpio® Cruciate Retaining (CR) Outcomes Study</brief_title>
  <official_title>An Open Label, Post-market, Non-randomized, Multi-center Study of the Outcomes of the Scorpio® Cruciate Retaining (CR) Total Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the design and functional performance of the
      Scorpio® Cruciate Retaining (CR) Total Knee System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design is a prospective, multi-center clinical trial. The Scorpio® Cruciate
      Retaining (CR) Total Knee System is to be implanted for evaluation in this study. This device
      system is commercially available and is intended for cemented use.

      The study group will consist of a maximum of 265 cases, requiring primary total knee
      replacement, and diagnosed with non-inflammatory arthritis. All subjects will be implanted
      with a femoral component, a tibial insert, a tibial tray and a resurfaced patella. Subjects
      receiving bilateral total knee replacements will represent two cases. Study participants will
      be recruited from 5 institutions.

      Subjects will be evaluated preoperatively and at follow-up intervals of 7 wks (± 2 wks), 3
      months (± 3 weeks), 6 months (optional visit), 12 months (± 2 months) and annually thereafter
      (± 2 months). Each subject will be followed for 15 years post-implantation.

      The objectives of this study are to:

        1. Evaluate the effect of system component design on functional performance.

        2. Evaluate the effect of system component design by comparing postoperative functional and
           radiographic findings with preoperative.

        3. Evaluate complications and the rates in which they occur.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Terminated due to lagging follow-up.
  </why_stopped>
  <start_date>June 2001</start_date>
  <primary_completion_date type="Actual">July 23, 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate Component Design Effect on Functional Knee Society Score and Radiographic Findings.</measure>
    <time_frame>15 years</time_frame>
    <description>This study was terminated prior to the protocol defined 15 year endpoint. As such, final outcome measures cannot be posted.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate Complication Rate.</measure>
    <time_frame>15 years</time_frame>
    <description>This study was terminated prior to the protocol defined 15 year endpoint. As such, final outcome measures cannot be posted.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Arthropathy of Knee</condition>
  <arm_group>
    <arm_group_label>Scorpio® CR Total Knee System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Scorpio® CR Total Knee System Study Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Scorpio® CR Total Knee System</intervention_name>
    <description>All subjects will be implanted with a femoral component, a tibial insert, a tibial tray and a resurfaced patella.</description>
    <arm_group_label>Scorpio® CR Total Knee System</arm_group_label>
    <other_name>Scorpio® Cruciate Retaining (CR) Total Knee System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject is a male or non-pregnant female between the ages of 21-80.

          2. The subject requires a primary cemented total knee replacement.

          3. The subject has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or
             avascular necrosis (AVN).

          4. The subject has intact collateral ligaments.

          5. The subject has signed the IRB approved, study specific Informed Patient Consent Form.

          6. The subject is willing and able to comply with postoperative scheduled clinical and
             radiographic evaluations and rehabilitation.

        Exclusion Criteria:

          1. Patient has inflammatory arthritis.

          2. The subject is morbidly obese, &gt;60% over ideal body weight for frame and height.

          3. The subject has a history of total or unicompartmental reconstruction of the affected
             joint.

          4. Patient has had a high tibial osteotomy or femoral osteotomy.

          5. The subject has a neuromuscular or neurosensory deficiency, which would limit the
             ability to assess the performance of the device.

          6. The subject has a systemic or metabolic disorder leading to progressive bone
             deterioration.

          7. The subject is immunologically suppressed, or receiving steroids in excess of normal
             physiological requirements.

          8. The subject's bone stock is compromised by disease or infection which cannot provide
             adequate support and/or fixation to the prosthesis.

          9. The subject has had a knee fusion to the affected joint.

         10. The subject has an active or suspected latent infection in or about the knee joint.

         11. The subject is a prisoner.

         12. The subject is pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>C. Lowry Barnes, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Foundation for Musculoskeletal Research and Education</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence Morawa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dearborn Orthopaedics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arthur Malkani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jewish Physician Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frank Kolisek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Research Foundation, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Harwin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Foundation for Musculoskeletal Research and Education</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Research Foundation, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewish Physician Group</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dearborn Orthopaedics</name>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2009</study_first_submitted>
  <study_first_submitted_qc>August 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2009</study_first_posted>
  <results_first_submitted>November 9, 2012</results_first_submitted>
  <results_first_submitted_qc>February 12, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 15, 2013</results_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis, traumatic arthritis, avascular necrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>215/229 subjects/cases enrolled and 5 subjects/cases censored=210/224 subjects/cases started</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Scorpio® CR Device</title>
          <description>All subjects were implanted with the Scorpio® CR Total Knee System Study Device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="210"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">Study was terminated prior to reaching 15 year endpoint.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="210"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable to return</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unwilling to return</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Intercurrent illness</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Revision / Removal of Study Implant</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Overall Study Termination</title>
              <participants_list>
                <participants group_id="P1" count="145"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Scorpio® CR Total Knee System Study Device</title>
          <description>All subjects were implanted with the Scorpio® CR Knee Arthroplasty Study Device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="210"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>For participants who had both knees replaced and enrolled in the study, the age at the time of the first surgery was used.
One 81 year old participant was enrolled in error and was considered a protocol deviation case, but remained in the study.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.46" spread="8.98" lower_limit="38" upper_limit="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="137"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Evaluate Component Design Effect on Functional Knee Society Score and Radiographic Findings.</title>
        <description>This study was terminated prior to the protocol defined 15 year endpoint. As such, final outcome measures cannot be posted.</description>
        <time_frame>15 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Scorpio® CR Device</title>
            <description>All subjects received the Scorpio® CR Device</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluate Component Design Effect on Functional Knee Society Score and Radiographic Findings.</title>
          <description>This study was terminated prior to the protocol defined 15 year endpoint. As such, final outcome measures cannot be posted.</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluate Complication Rate.</title>
        <description>This study was terminated prior to the protocol defined 15 year endpoint. As such, final outcome measures cannot be posted.</description>
        <time_frame>15 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Scorpio® CR Device</title>
            <description>All subjects received the Scorpio® CR Device</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluate Complication Rate.</title>
          <description>This study was terminated prior to the protocol defined 15 year endpoint. As such, final outcome measures cannot be posted.</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>There were a total of 8 serious adverse events reported in 6 subjects.</desc>
      <group_list>
        <group group_id="E1">
          <title>Scorpio® CR Total Knee System Study Device</title>
          <description>All subjects were implanted with the Scorpio® CR Knee Arthroplasty Study Device</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection and Infestations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal and Connective Tissue Disorders (Non-operative site)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="210"/>
              </event>
              <event>
                <sub_title>Musculoskeletal and Connective Tissue Disorder (Operative Site)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nervous System Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal and Connective Tissue Disorders - (Operative Site)</sub_title>
                <counts group_id="E1" events="68" subjects_affected="53" subjects_at_risk="210"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The disclosure restriction on the PI to publish results of this Clinical Study or the results of the activities hereunder, any abstract, manuscript, presentation or other communication shall be submitted to sponsor for review and approval at least 60 days prior to submission for publication. The sponsor retains the right to deny publication or, at its sole option, to revise the manuscript to delete proprietary or other confidential commercial information.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study was terminated early due to lagging follow up prior to the 15 year endpoint.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Director of Clinical Research</name_or_title>
      <organization>Stryker Orthopaedics®</organization>
      <phone>201-831-5401</phone>
      <email>ellen.axelson@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

